Plenge Robert M

Insider CIK 1773367 · BMRN Director · BMY EVP, Chief Research Officer · TBIO Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
BMRN BIOMARIN PHARMACEUTICAL IN	A Award	2026-09-10	2026-09-14	6,140	—	$0	6,140	SEC↗
BMRN BIOMARIN PHARMACEUTICAL IN	A Award	2026-09-10	2026-09-14	6,140	—	$0	6,140	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise deriv	2026-03-10	2026-03-12	1,107	—	$0	0	SEC↗
BMY BRISTOL MYERS SQUIBB CO	A Award deriv	2026-03-10	2026-03-12	26,939	—	$0	26,939	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise deriv	2026-03-10	2026-03-12	2,342	—	$0	2,342	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise deriv	2026-03-10	2026-03-12	14,052	—	$0	0	SEC↗
BMY BRISTOL MYERS SQUIBB CO	A Award deriv	2026-03-10	2026-03-12	17,959	—	$0	17,959	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise	2026-03-10	2026-03-12	14,052	—	$0	31,600	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise	2026-03-10	2026-03-12	1,107	—	$0	16,946	SEC↗
BMY BRISTOL MYERS SQUIBB CO	J Other	2026-03-10	2026-03-12	124	—	$0	16,822	SEC↗
BMY BRISTOL MYERS SQUIBB CO	F Tax w/h	2026-03-10	2026-03-12	436	$60.13	$26.2K	16,386	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise	2026-03-10	2026-03-12	2,342	—	$0	18,728	SEC↗
BMY BRISTOL MYERS SQUIBB CO	J Other	2026-03-10	2026-03-12	253	—	$0	18,475	SEC↗
BMY BRISTOL MYERS SQUIBB CO	F Tax w/h	2026-03-10	2026-03-12	927	$60.13	$55.7K	17,548	SEC↗
BMY BRISTOL MYERS SQUIBB CO	J Other	2026-03-10	2026-03-12	6,900	—	$0	24,700	SEC↗
BMY BRISTOL MYERS SQUIBB CO	F Tax w/h	2026-03-10	2026-03-12	3,172	$60.13	$190.7K	21,528	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise deriv	2025-03-10	2025-03-12	1,165	—	$0	0	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise deriv	2025-03-10	2025-03-12	1,107	—	$0	1,107	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise deriv	2025-03-10	2025-03-12	2,342	—	$0	4,684	SEC↗
BMY BRISTOL MYERS SQUIBB CO	A Award deriv	2025-03-10	2025-03-12	23,431	—	$0	23,431	SEC↗
BMY BRISTOL MYERS SQUIBB CO	A Award deriv	2025-03-10	2025-03-12	35,146	—	$0	35,146	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise deriv	2025-03-10	2025-03-12	6,641	—	$0	0	SEC↗
BMY BRISTOL MYERS SQUIBB CO	F Tax w/h	2025-03-10	2025-03-12	406	$63.11	$25.6K	12,426	SEC↗
BMY BRISTOL MYERS SQUIBB CO	J Other	2025-03-10	2025-03-12	2,449	—	$0	17,699	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise	2025-03-10	2025-03-12	6,641	—	$0	20,148	SEC↗
BMY BRISTOL MYERS SQUIBB CO	F Tax w/h	2025-03-10	2025-03-12	862	$63.11	$54.4K	13,507	SEC↗
BMY BRISTOL MYERS SQUIBB CO	J Other	2025-03-10	2025-03-12	399	—	$0	14,369	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise	2025-03-10	2025-03-12	2,342	—	$0	14,768	SEC↗
BMY BRISTOL MYERS SQUIBB CO	F Tax w/h	2025-03-10	2025-03-12	1,860	$63.11	$117.4K	15,839	SEC↗
BMY BRISTOL MYERS SQUIBB CO	J Other	2025-03-10	2025-03-12	193	—	$0	12,832	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise	2025-03-10	2025-03-12	1,107	—	$0	13,025	SEC↗
BMY BRISTOL MYERS SQUIBB CO	F Tax w/h	2025-03-10	2025-03-12	482	$63.11	$30.4K	11,918	SEC↗
BMY BRISTOL MYERS SQUIBB CO	J Other	2025-03-10	2025-03-12	80	—	$0	12,400	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise	2025-03-10	2025-03-12	1,165	—	$0	12,480	SEC↗
BMY BRISTOL MYERS SQUIBB CO	A Award deriv	2024-03-10	2024-03-12	23,220	—	$0	23,220	SEC↗
BMY BRISTOL MYERS SQUIBB CO	J Other deriv	2024-03-10	2024-03-12	2,342	—	$0	7,026	SEC↗
BMY BRISTOL MYERS SQUIBB CO	A Award deriv	2024-03-10	2024-03-12	15,480	—	$0	15,480	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise deriv	2024-03-10	2024-03-12	6,985	—	$0	0	SEC↗
BMY BRISTOL MYERS SQUIBB CO	J Other deriv	2024-03-10	2024-03-12	1,107	—	$0	2,214	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise deriv	2024-03-10	2024-03-12	994	—	$0	0	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise deriv	2024-03-10	2024-03-12	1,164	—	$0	1,165	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise	2024-03-10	2024-03-12	6,985	—	$0	15,182	SEC↗
BMY BRISTOL MYERS SQUIBB CO	J Other	2024-03-10	2024-03-12	157	—	$0	7,763	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise	2024-03-10	2024-03-12	994	—	$0	7,920	SEC↗
BMY BRISTOL MYERS SQUIBB CO	F Tax w/h	2024-03-10	2024-03-12	1,436	$53.79	$77.2K	11,315	SEC↗
BMY BRISTOL MYERS SQUIBB CO	J Other	2024-03-10	2024-03-12	2,431	—	$0	12,751	SEC↗
BMY BRISTOL MYERS SQUIBB CO	F Tax w/h	2024-03-10	2024-03-12	283	$53.79	$15.2K	8,197	SEC↗
BMY BRISTOL MYERS SQUIBB CO	J Other	2024-03-10	2024-03-12	201	—	$0	8,480	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise	2024-03-10	2024-03-12	1,164	—	$0	8,681	SEC↗
BMY BRISTOL MYERS SQUIBB CO	F Tax w/h	2024-03-10	2024-03-12	246	$53.79	$13.2K	7,517	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise deriv	2023-12-02	2023-12-05	616	—	$0	0	SEC↗
BMY BRISTOL MYERS SQUIBB CO	F Tax w/h	2023-12-02	2023-12-05	274	$50.10	$13.7K	6,926	SEC↗
BMY BRISTOL MYERS SQUIBB CO	M Exercise	2023-12-02	2023-12-05	616	—	$0	7,200	SEC↗
BMY BRISTOL MYERS SQUIBB CO	S Sale	2023-08-03	2023-08-07	732	$61.14	$44.8K	6,584	SEC↗
TBIO Translate Bio, Inc.	S Sale deriv	2021-09-14	2021-09-14	20,000	—	$0	0	SEC↗
TBIO Translate Bio, Inc.	S Sale deriv	2021-09-14	2021-09-14	18,900	—	$0	0	SEC↗
TBIO Translate Bio, Inc.	S Sale deriv	2021-09-14	2021-09-14	37,800	—	$0	0	SEC↗
TBIO Translate Bio, Inc.	S Sale deriv	2021-09-14	2021-09-14	18,900	—	$0	0	SEC↗
TBIO Translate Bio, Inc.	A Award deriv	2021-06-16	2021-06-16	20,000	—	$0	20,000	SEC↗
TBIO Translate Bio, Inc.	A Award deriv	2020-06-16	2020-06-16	18,900	—	$0	18,900	SEC↗
TBIO Translate Bio, Inc.	A Award deriv	2019-06-18	2019-06-19	18,900	—	$0	18,900	SEC↗
TBIO Translate Bio, Inc.	A Award deriv	2019-04-10	2019-04-11	37,800	—	$0	37,800	SEC↗